| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $5.2M | -1.5% | +178.4% |
| Cost of Revenue | $3.4M | — | +101.1% |
| Gross Profit | $1.9M | +134.2% | +782.2% |
| R&D Expense | $9K | — | — |
| SG&A Expense | $1.7M | — | +60.5% |
| Operating Income | $118K | +116.0% | +113.4% |
| Pre-tax Income | -$167K | — | +82.5% |
| Income Tax | $1K | — | -93.8% |
| Net Income | -$168K | -55.6% | +82.7% |
| EPS (Basic) | -$0.03 | +82.4% | +88.9% |
| EPS (Diluted) | -$0.03 | +82.4% | +88.9% |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $762K | — | — |
| Accounts Receivable | $4.6M | -24.3% | — |
| Inventory | $1.8M | — | — |
| Current Assets | $7.6M | -6.6% | — |
| Total Assets | $9.1M | -5.6% | — |
| Current Liabilities | $10.6M | — | — |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$1.3M | — | — |
| Investing Cash Flow | $250K | — | — |
| Financing Cash Flow | $1.8M | — | — |
| Long-term Debt | $4.2M | — | — |
| Total Liabilities | $14.1M | — | — |
| Stockholders' Equity | -$5.1M | -3.4% | -46.7% |